November 20, 2018
Video
The director of Parkinson’s Disease and Movement Disorders Program at Henry Ford Hospital discussed this pipeline of therapies and the enhancement of the clinical understanding of the disease.
The Success of the Jefferson Mobile Stroke Unit: Alvin Wang, DO, BC-EMS
Progress in Neurogenerative Disease Drug Development: Gregory A. Rippon, MD, MS
Diazepam Nasal Spray Significantly Extends Time Between Seizure Clusters
Reactions to FDA Advisory Panel Decision on AMX0035: Justin Klee; Josh Cohen, BSc